Robyn Karnauskas
Stock Analyst at Truist Financial
Total Price Targets
6
Stocks Covered
6
Sectors
Healthcare
Most Recent
Dec 18, 2024
Stocks Covered by Robyn Karnauskas
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | $32.00 | $26.38 | +21.3% | 1 | Dec 18, 2024 |
| FATE | Fate Therapeutics, Inc. | $7.00 | $1.55 | +350.2% | 1 | Jan 5, 2023 |
| GILD | Gilead Sciences, Inc. | $91.00 | $132.04 | -31.1% | 1 | Oct 28, 2022 |
| BMRN | BioMarin Pharmaceutical Inc. | $133.00 | $54.20 | +145.4% | 1 | Sep 12, 2022 |
| ABBV | AbbVie Inc. | $160.00 | $206.29 | -22.4% | 1 | Feb 21, 2022 |
| BIIB | Biogen Inc. | $320.00 | $186.69 | +71.4% | 1 | Feb 16, 2022 |
Recent Activity
- Dec 18, 2024— Set$32.00price target onPFE(Pfizer Inc.)
- Jan 5, 2023— Set$7.00price target onFATE(Fate Therapeutics, Inc.)
- Oct 28, 2022— Set$91.00price target onGILD(Gilead Sciences, Inc.)
- Sep 12, 2022— Set$133.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Feb 21, 2022— Set$160.00price target onABBV(AbbVie Inc.)
- Feb 16, 2022— Set$320.00price target onBIIB(Biogen Inc.)
Frequently Asked Questions
Who is Robyn Karnauskas?
Robyn Karnauskas is a stock analyst at Truist Financial covering 6 stocks primarily in Healthcare. They have issued 6 price targets since Feb 16, 2022.
What stocks does Robyn Karnauskas cover?
Robyn Karnauskas currently covers 6 stocks, including PFE, FATE, GILD, BMRN, ABBV.
What is Robyn Karnauskas's latest price target?
Robyn Karnauskas's most recent price target was $32.00 on PFE (Pfizer Inc.), set on Dec 18, 2024.
What is Robyn Karnauskas's highest price target?
Robyn Karnauskas's highest issued price target is $320.00 on BIIB, set on Feb 16, 2022.
More Analysts at Truist Financial
Coverage based on publicly published price targets. Not investment advice.